These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1572027)

  • 21. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
    Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limitations and late complications of third-generation automatic cardioverter-defibrillators.
    Nunain SO; Roelke M; Trouton T; Osswald S; Kim YH; Sosa-Suarez G; Brooks DR; McGovern B; Guy M; Torchiana DF
    Circulation; 1995 Apr; 91(8):2204-13. PubMed ID: 7697850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term arrhythmic outcome in survivors of ventricular fibrillation with absence of inducible ventricular tachycardia.
    Zheutlin TA; Steinman RT; Mattioni TA; Kehoe RF
    Am J Cardiol; 1988 Dec; 62(17):1213-7. PubMed ID: 3195483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Device interaction--antitachycardia pacemakers and defibrillators for sustained ventricular tachycardia.
    Ahern TS; Nydegger C; McCormick DJ; Marinchak R; Kowey P; Horowitz LN; Worley S; Kutalek SP
    Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 2):302-7. PubMed ID: 1706842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysrhythmias after direct-current cardioversion.
    Waldecker B; Brugada P; Zehender M; Stevenson W; Wellens HJ
    Am J Cardiol; 1986 Jan; 57(1):120-3. PubMed ID: 3510522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular tachycardia/fibrillation: therapeutic alternatives.
    Fisher JD; Kim SG; Roth JA; Ferrick KJ; Brodman RF; Gross JN; Furman S
    Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 2):370-5. PubMed ID: 1706855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shock avoidance and the newer tachycardia therapy algorithms.
    Rajamani K; Goldberg AS; Wilkoff BL
    Cardiol Clin; 2014 May; 32(2):191-200. PubMed ID: 24793796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of implantable cardioverter defibrillator therapy in the management of high-risk patients.
    Akhtar M; Avitall B; Jazayeri M; Tchou P; Troup P; Sra J; Axtell K
    Circulation; 1992 Jan; 85(1 Suppl):I131-9. PubMed ID: 1728496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indications for different modes of surgical therapy in medically refractory ventricular arrhythmias.
    Hammon JW; Echt DS; Merrill WH; Primm KR; Woosley RL; Smith RF; Roden DM; Bender HW
    Ann Surg; 1986 Jun; 203(6):679-84. PubMed ID: 3718030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of a tiered therapy defibrillator system used to treat recurrent ventricular arrhythmias refractory to drugs.
    Rankin AC; Zaim S; Powell A; Zaim B; Brooks R; McGovern BA; Garan H; Ruskin JN
    Br Heart J; 1993 Jul; 70(1):61-9. PubMed ID: 8038001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current role of the automatic implantable cardioverter-defibrillator in the treatment of life-threatening ventricular arrhythmias.
    Kay GN; Plumb VJ; Dailey SM; Epstein AE
    Am J Med; 1990 Jan; 88(1N):25N-34N. PubMed ID: 2195882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of telemetry functions in the assessment of implanted antitachycardia device efficacy.
    Newman D; Dorian P; Downar E; Harris L; Cameron D; Waxman M; Hamilton R; Gow R; Hardy J
    Am J Cardiol; 1992 Sep; 70(6):616-21. PubMed ID: 1510010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Holter documented sudden death in a patient with an implanted defibrillator.
    Birgersdotter-Green U; Rosenqvist M; Lindemans FW; Rydén L; Rådegran K
    Pacing Clin Electrophysiol; 1992 Jul; 15(7):1008-14. PubMed ID: 1378592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Atrial defibrillator].
    Jung W; Lüderitz B
    Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early experience with an implantable cardioverter.
    Zipes DP; Heger JJ; Miles WM; Mahomed Y; Brown JW; Spielman SR; Prystowsky EN
    N Engl J Med; 1984 Aug; 311(8):485-90. PubMed ID: 6749205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of antitachycardia devices in the treatment of ventricular tachyarrhythmias.
    Lüderitz B; Manz M
    Am J Cardiol; 1989 Dec; 64(20):75J-78J. PubMed ID: 2596414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventricular arrhythmias: medical therapy, device treatment, and indications for electrophysiologic study.
    Sager PT; Batsford WP
    Cardiol Clin; 1988 Feb; 6(1):37-47. PubMed ID: 3048673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of electrical pacing and automatic cardioversion defibrillation for normal cardiac function recovery.
    Pekarsky V; Astrakhantsev Y; Belenkov Y; Gimrikh E; Oferkin A; Maslov M; Popov S; Pekarskaya M; Markov V; Vasiltsev Y
    Pacing Clin Electrophysiol; 1986 Nov; 9(6 Pt 2):1349-55. PubMed ID: 2432561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.